Caricamento...
Case Studies in the Management of Metastatic Breast Cancer with Eribulin
Outcomes for triple-negative or hormone-refractory metastatic breast cancer (MBC) are poor and treatment options are limited. Described herein are cases of two women who developed MBC following adjuvant chemotherapy and endocrine therapy for human epidermal growth factor receptor 2 (HER2)-negative d...
Salvato in:
| Pubblicato in: | Clin Med Insights Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Libertas Academica
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607072/ https://ncbi.nlm.nih.gov/pubmed/26508896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S27962 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|